These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 39146761)

  • 1. Design and structure-activity relationships of ether-linked alkylides: Hybrids of 3-O-descladinosyl macrolides and quinolone motifs.
    Zhang N; Liu WT; Cui XY; Liu SM; Ma CX; Liang JH
    Bioorg Chem; 2024 Oct; 151():107712. PubMed ID: 39146761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and structure-activity relationships of novel macrolones: Hybrids of 2-fluoro 9-oxime ketolides and carbamoyl quinolones with highly improved activity against resistant pathogens.
    Ma CX; Lv W; Li YX; Fan BZ; Han X; Kong FS; Tian JC; Cushman M; Liang JH
    Eur J Med Chem; 2019 May; 169():1-20. PubMed ID: 30852383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships and mechanism of action of macrolides derived from erythromycin as antibacterial agents.
    Liang JH; Han X
    Curr Top Med Chem; 2013; 13(24):3131-64. PubMed ID: 24200358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and structure-activity relationships of novel 15-membered macrolides: Quinolone/quinoline-containing sidechains tethered to the C-6 position of azithromycin acylides.
    Fan BZ; Hiasa H; Lv W; Brody S; Yang ZY; Aldrich C; Cushman M; Liang JH
    Eur J Med Chem; 2020 May; 193():112222. PubMed ID: 32200200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and structure-activity relationships of novel non-ketolides: 9-Oxime clarithromycin featured with seven-to thirteen-atom-length diamine linkers at 3-OH.
    Ma CX; Liu WT; Li XM; Ding J; Liu SM; Xue F; Li Y; Liang JH
    Eur J Med Chem; 2024 Oct; 276():116630. PubMed ID: 38972081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
    Mazzariol A; Koncan R; Vitali LA; Cornaglia G
    J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships of novel alkylides: 3-O-arylalkyl clarithromycin derivatives with improved antibacterial activities.
    Liang JH; Li XL; Wang H; An K; Wang YY; Xu YC; Yao GW
    Eur J Med Chem; 2012 Mar; 49():289-303. PubMed ID: 22301216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antibacterial activity of modithromycin, a novel 6,11-bridged bicyclolide, against respiratory pathogens, including macrolide-resistant Gram-positive cocci.
    Sato T; Tateda K; Kimura S; Iwata M; Ishii Y; Yamaguchi K
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1588-93. PubMed ID: 21220534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibilities of Streptococcus pyogenes and Streptococcus pneumoniae to macrolides and telithromycin: data from an Italian multicenter study.
    Mazzariol A; Koncan R; Bahar G; Cornaglia G
    J Chemother; 2007 Oct; 19(5):500-7. PubMed ID: 18073148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New macrolides active against Streptococcus pyogenes with inducible or constitutive type of macrolide-lincosamide-streptogramin B resistance.
    Fernandes PB; Baker WR; Freiberg LA; Hardy DJ; McDonald EJ
    Antimicrob Agents Chemother; 1989 Jan; 33(1):78-81. PubMed ID: 2523688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antibacterial evaluation of novel clarithromycin derivatives with C-4″ elongated arylalkyl groups against macrolide-resistant strains.
    Ma S; Jiao B; Ju Y; Zheng M; Ma R; Liu L; Zhang L; Shen X; Ma C; Meng Y; Wang H; Qi Y; Ma X; Cui W
    Eur J Med Chem; 2011 Feb; 46(2):556-66. PubMed ID: 21159410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An examination of the differential sensitivity to ketolide antibiotics in ermB strains of Streptococcus pyogenes and Streptococcus pneumoniae.
    Champney WS; Mentens N; Zurawick K
    Curr Microbiol; 2004 Oct; 49(4):239-47. PubMed ID: 15386111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of telithromycin (HMR 3647) against Greek Streptococcus pyogenes and Streptococcus pneumoniae clinical isolates with different macrolide susceptibilities.
    Ioannidou S; Tassios PT; Zachariadou L; Salem Z; Kanelopoulou M; Kanavaki S; Chronopoulou G; Petropoulou N; Foustoukou M; Pangalis A; Trikka-Graphakos E; Papafraggas E; Vatopoulos AC
    Clin Microbiol Infect; 2003 Jul; 9(7):704-7. PubMed ID: 12925112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenes.
    Nagai K; Davies TA; Ednie LM; Bryskier A; Palavecino E; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3242-5. PubMed ID: 11600391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anhydrolide macrolides. 2. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbazate erythromycin A analogues.
    Griesgraber G; Kramer MJ; Elliott RL; Nilius AM; Ewing PJ; Raney PM; Bui MH; Flamm RK; Chu DT; Plattner JJ; Or YS
    J Med Chem; 1998 May; 41(10):1660-70. PubMed ID: 9572891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of macrolones with central piperazine ring in the linker and its influence on antibacterial activity.
    Kapić S; Cipčić Paljetak H; Palej Jakopović I; Fajdetić A; Ilijaš M; Stimac V; Brajša K; Holmes DJ; Berge J; Alihodžić S
    Bioorg Med Chem; 2011 Dec; 19(23):7281-98. PubMed ID: 22047805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological activity of 4''-O-acyl derivatives of 14- and 15-membered macrolides linked to omega-quinolone-carboxylic unit.
    Skugor MM; Stimac V; Palej I; Lugarić D; Paljetak HC; Filić D; Modrić M; Dilović I; Gembarovski D; Mutak S; Eraković Haber V; Holmes DJ; Ivezić-Schoenfeld Z; Alihodzić S
    Bioorg Med Chem; 2010 Sep; 18(17):6547-58. PubMed ID: 20621489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of ketolides telithromycin and HMR 3004 against italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility.
    Giovanetti E; Montanari MP; Marchetti F; Varaldo PE
    J Antimicrob Chemother; 2000 Dec; 46(6):905-8. PubMed ID: 11102408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and characterization of macrolide resistance in clinical isolates of Streptococcus pneumoniae and Streptococcus pyogenes from North America.
    Hoban DJ
    J Chemother; 2002 Jul; 14 Suppl 3():25-30. PubMed ID: 12418558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antibacterial evaluation of novel 11-O-carbamoyl clarithromycin ketolides.
    Jia L; Yan M; Shen Y; Qin Y; Qiang S; Ma S
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3693-3697. PubMed ID: 28711353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.